XOMAP Q4 2019 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$422,000-75.0% YoY

Gross Profit

$292,00069.2% margin

Operating Income

-$4M-948.1% margin

Net Income

-$4M-1023.9% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

-95.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$715,000

Balance Sheet

Total Assets

$96M

Total Liabilities

$52M

Stockholders' Equity

$44M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$422,000	$2M	-75.0%
Gross Profit	$292,000	$1M	-79.8%
Operating Income	-$4M	-$3M	-16.9%
Net Income	-$4M	-$3M	-43.5%